Carrington Laboratories, Inc.

Material Handling & Storage

Carrington Subsidiary DelSite Demonstrates Usefulness of GelSite® Polymer for Therapeutic Delivery of Proteins and Peptides at Controlled Release Society Meeting

Carrington Subsidiary DelSite Demonstrates Usefulness of GelSite(R) Polymer for Therapeutic Delivery of Proteins and Peptides at Controlled Release Society Meeting o Presented at Controlled Release Society Meeting o Versatile Excipient Has Sustained Release Capabilities o Mucoadhesive and Stabilizes Proteins and Peptides IRVING, Texas, July 12 / / - Carrington Laboratories, Inc. (NASDAQ:CARN)...

Read More »
Material Handling & Storage

Carrington Subsidiary DelSite Demonstrates Usefulness of GelSite-® Polymer for Therapeutic Delivery of Proteins and Peptides at Controlled Release Society Meeting

Carrington Subsidiary DelSite Demonstrates Usefulness of GelSite(R) Polymer for Therapeutic Delivery of Proteins and Peptides at Controlled Release Society Meeting o Presented at Controlled Release Society Meeting o Versatile Excipient Has Sustained Release Capabilities o Mucoadhesive and Stabilizes Proteins and Peptides IRVING, Texas, July 12 / / - Carrington Laboratories, Inc. (NASDAQ:CARN)...

Read More »
Health, Medical, & Dental Supplies and Equipment

Carrington Subsidiary in Pact for Development of Vaccine for Bacillary Dysentery (Shigellosis) Using DelSite's Nasal Powder Delivery System

IRVING, Texas, Jan. 10 : Carrington Laboratories, Inc. (NASDAQ:CARN) today announced its wholly-owned subsidiary, DelSite Biotechnologies, Inc., granted a non-exclusive license to EndoBiologics, Inc. of Missoula, Montana for the purpose of developing and evaluating investigational conjugate vaccines against bacillary dysentery (shigellosis) and other bacterial diseases using DelSite's nasal...

Read More »
Health, Medical, & Dental Supplies and Equipment

Carrington Subsidiary in Pact for Development of Vaccine for Bacillary Dysentery (Shigellosis) Using DelSite's Nasal Powder Delivery System

IRVING, Texas, Jan. 10 : Carrington Laboratories, Inc. (NASDAQ:CARN) today announced its wholly-owned subsidiary, DelSite Biotechnologies, Inc., granted a non-exclusive license to EndoBiologics, Inc. of Missoula, Montana for the purpose of developing and evaluating investigational conjugate vaccines against bacillary dysentery (shigellosis) and other bacterial diseases using DelSite's nasal...

Read More »
Material Handling & Storage

DelSite Presents New Data on GelSite® Nasal Powder Delivery System at Controlled Release Society Meeting

GelSite-® Polymer Has a Distinct Chemical and Biological Function Uniquely Suited to Meet the Challenges Faced in a Pandemic Flu IRVING, Texas, July 26 // -- Carrington Laboratories, Inc. (NASDAQ:CARN) today announced that Dr. Paul Stroud, Director of Polymer Research and Development at DelSite Biotechnologies, Inc., Carrington's wholly-owned subsidiary, presented the latest findings on the...

Read More »
Material Handling & Storage

DelSite Presents New Data on GelSite-® Nasal Powder Delivery System at Controlled Release Society Meeting

GelSiteÂ-® Polymer Has a Distinct Chemical and Biological Function Uniquely Suited to Meet the Challenges Faced in a Pandemic Flu IRVING, Texas, July 26 // -- Carrington Laboratories, Inc. (NASDAQ:CARN) today announced that Dr. Paul Stroud, Director of Polymer Research and Development at DelSite Biotechnologies, Inc., Carrington's wholly-owned subsidiary, presented the latest findings on the...

Read More »
Material Handling & Storage

Carrington Subsidiary DelSite Demonstrates Usefulness of GelSite® Polymer for Therapeutic Delivery of Proteins and Peptides at Controlled Release Society Meeting

Carrington Subsidiary DelSite Demonstrates Usefulness of GelSite(R) Polymer for Therapeutic Delivery of Proteins and Peptides at Controlled Release Society Meeting o Presented at Controlled Release Society Meeting o Versatile Excipient Has Sustained Release Capabilities o Mucoadhesive and Stabilizes Proteins and Peptides IRVING, Texas, July 12 / / - Carrington Laboratories, Inc. (NASDAQ:CARN)...

Read More »
Material Handling & Storage

Carrington Subsidiary DelSite Demonstrates Usefulness of GelSite-® Polymer for Therapeutic Delivery of Proteins and Peptides at Controlled Release Society Meeting

Carrington Subsidiary DelSite Demonstrates Usefulness of GelSite(R) Polymer for Therapeutic Delivery of Proteins and Peptides at Controlled Release Society Meeting o Presented at Controlled Release Society Meeting o Versatile Excipient Has Sustained Release Capabilities o Mucoadhesive and Stabilizes Proteins and Peptides IRVING, Texas, July 12 / / - Carrington Laboratories, Inc. (NASDAQ:CARN)...

Read More »
Company News

Carrington Signs Term Sheet with AM Labs for Distribution of Oral Products to Retail Markets

Strategic Sales and Marketing Partnership Opens New Opportunities for Carrington's Professionally Promoted Oral Technology Products in Consumer Markets IRVING, Texas, March 19 -- Carrington Laboratories, Inc. (NASDAQ:CARN) announced today it has signed a term sheet with AM Laboratories to co-brand Carrington's oral technology line of oral patches and rinses. The patches are used for the...

Read More »
Company News

Carrington Signs Term Sheet with AM Labs for Distribution of Oral Products to Retail Markets

Strategic Sales and Marketing Partnership Opens New Opportunities for Carrington's Professionally Promoted Oral Technology Products in Consumer Markets IRVING, Texas, March 19 -- Carrington Laboratories, Inc. (NASDAQ:CARN) announced today it has signed a term sheet with AM Laboratories to co-brand Carrington's oral technology line of oral patches and rinses. The patches are used for the...

Read More »
Company News

Carrington and Racing Legend Johnny Rutherford Sign Endorsement and Personal Services Agreement

IRVING, Texas, Feb. 8: Carrington Laboratories, Inc. (NASDAQ:CARN) announced today it has entered into a one-year endorsement and personal services agreement with racing legend Johnny Rutherford. The partnership provides a platform for Carrington to reach the rapidly growing and attractive racing enthusiast consumer market. Under the terms of the agreement, Carrington will develop, market and...

Read More »
Company News

Carrington and Racing Legend Johnny Rutherford Sign Endorsement and Personal Services Agreement

IRVING, Texas, Feb. 8: Carrington Laboratories, Inc. (NASDAQ:CARN) announced today it has entered into a one-year endorsement and personal services agreement with racing legend Johnny Rutherford. The partnership provides a platform for Carrington to reach the rapidly growing and attractive racing enthusiast consumer market. Under the terms of the agreement, Carrington will develop, market and...

Read More »
Health, Medical, & Dental Supplies and Equipment

Carrington Subsidiary in Pact for Development of Vaccine for Bacillary Dysentery (Shigellosis) Using DelSite's Nasal Powder Delivery System

IRVING, Texas, Jan. 10 : Carrington Laboratories, Inc. (NASDAQ:CARN) today announced its wholly-owned subsidiary, DelSite Biotechnologies, Inc., granted a non-exclusive license to EndoBiologics, Inc. of Missoula, Montana for the purpose of developing and evaluating investigational conjugate vaccines against bacillary dysentery (shigellosis) and other bacterial diseases using DelSite's nasal...

Read More »
Health, Medical, & Dental Supplies and Equipment

Carrington Subsidiary in Pact for Development of Vaccine for Bacillary Dysentery (Shigellosis) Using DelSite's Nasal Powder Delivery System

IRVING, Texas, Jan. 10 : Carrington Laboratories, Inc. (NASDAQ:CARN) today announced its wholly-owned subsidiary, DelSite Biotechnologies, Inc., granted a non-exclusive license to EndoBiologics, Inc. of Missoula, Montana for the purpose of developing and evaluating investigational conjugate vaccines against bacillary dysentery (shigellosis) and other bacterial diseases using DelSite's nasal...

Read More »
Company News

Carrington Launches New Corporate Website

oIncrease Corporate Awareness o Easier to Access DelSite's Website o Internet Marketing Campaign to Follow IRVING, Texas, Jan. 11 -- Carrington Laboratories, Inc., (NASDAQ:CARN) today announced they have launched a new corporate website. The redesigned website is located at Carrington's current URL of http://www.carringtonlabs.com/ and contains new features such as site search functionality,...

Read More »
Company News

Carrington Launches New Corporate Website

oIncrease Corporate Awareness o Easier to Access DelSite's Website o Internet Marketing Campaign to Follow IRVING, Texas, Jan. 11 -- Carrington Laboratories, Inc., (NASDAQ:CARN) today announced they have launched a new corporate website. The redesigned website is located at Carrington's current URL of http://www.carringtonlabs.com/ and contains new features such as site search functionality,...

Read More »

All Topics